Avalun, created in 2013 (France), belongs to our Top Web Popularity Medical Diagnostics & Research, from 28 sister brands and 2617 competing brands. Avalun is owned by Biosynex, listed on the stock exchange of Paris The ISIN, the company's International Securities Identification Number, is FR0011005933. Avalun is part of the Medical Diagnostics & Research activity sector.
Share price and profitability of the share Biosynex (Avalun)
Buy Biosynex share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Biosynex
(Avalun)
over 5 years*
EUR 12.00
Stock market history Biosynex (Avalun)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
